Table 1.
VEGF (n=39) | Placebo (n=11) | |
---|---|---|
Age (Mean, s.d.) | 61.4 +/− 9.9 | 65.6 +/− 8.4 |
Male | 18 (46%) | 1 (9%) |
Diabetes Type I | 7 (18%) | 0 |
Diabetes Type II | 32 (82%) | 11 (100%) |
Diabetes Duration (yrs) | 12.7 +/− 10.6 | 13.2 +/− 7.4 |
Insulin use | 17 (44%) | 7 (64%) |
Hgb A1C baseline | 7.6 +/− 1.4 | 7.6 +/− 2 |